APA (7th ed.) Citation

GD, R., N, W., R, Y., S, C., M, A., & K, W. (2023). Omadacycline in the treatment of community-acquired bacterial pneumonia in patients with comorbidities: A post-hoc analysis of the phase 3 OPTIC trial. Frontiers in medicine, 10, 1225710. https://doi.org/10.3389/fmed.2023.1225710

Chicago Style (17th ed.) Citation

GD, Rodriguez, Warren N, Yashayev R, Chitra S, Amodio-Groton M, and Wright K. "Omadacycline in the Treatment of Community-acquired Bacterial Pneumonia in Patients with Comorbidities: A Post-hoc Analysis of the Phase 3 OPTIC Trial." Frontiers in Medicine 10 (2023): 1225710. https://doi.org/10.3389/fmed.2023.1225710.

MLA (9th ed.) Citation

GD, Rodriguez, et al. "Omadacycline in the Treatment of Community-acquired Bacterial Pneumonia in Patients with Comorbidities: A Post-hoc Analysis of the Phase 3 OPTIC Trial." Frontiers in Medicine, vol. 10, 2023, p. 1225710, https://doi.org/10.3389/fmed.2023.1225710.